GenVec, Inc. (GNVC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.61-0.00 (-0.13%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.61
Bid0.00 x
Ask1.10 x 6000
Day's Range0.58 - 0.62
52wk Range0.35 - 3.69
1y Target EstN/A
Market Cap10.52M
P/E Ratio (ttm)-1.76
Avg Vol (3m)121,920
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals5 days ago

    GenVec faces delisting threat after it fails to raise share price

    Gaithersburg-based GenVec Inc. is facing the threat of market delisting, but for now it has a bit more time to raise its share price. The gene delivery company (GNVC) first received a warning from the Nasdaq Stock Market in February because its share price was below the $1 minimum for 30 consecutive days.

  • GenVec, Inc. :GNVC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
    Capital Cube21 days ago

    GenVec, Inc. :GNVC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016

    Categories: Yahoo Finance Click here to see latest analysis GenVec, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of GenVec, Inc. – Emergent BioSolutions Inc., Pfizer Inc., Novartis AG Sponsored ADR, Merck & Co., Inc., Sangamo BioSciences, Inc., Astrazeneca PLC Sponsored ADR and Johnson & Johnson ... Read more (Read more...)

  • PR Newswire25 days ago

    GenVec Reports Second Quarter 2016 Financial Results

    GAITHERSBURG, Md., Aug. 5, 2016 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today reported financial results for the second quarter ended June 30, 2016. For the three months ended June 30, 2016, the company ...